BioMarin Pharmaceutical

biomarin.com

BioMarin Pharmaceutical Inc. is a global biotechnology company focused on developing and commercializing innovative biopharmaceuticals for serious diseases and medical conditions. Since its founding in 1997, BioMarin has leveraged its scientific expertise to create transformative medicines for life-threatening conditions, including achondroplasia and severe hemophilia A. The company has eight marketed products and a robust pipeline of investigational medicines in various stages of development, positioning it as a leader in the biotechnology sector with a strong commitment to patient care and scientific advancement.